A significant advance in cancer study is emerging with the use of mini-antibodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently disabled in several kinds of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research